Hroniss Grasu

Center

Age: 32
Free Agency: 2024 (UFA)
Accrued Seasons: 7
  • 2023 Salary Cap Charge: $0 (0.00% of cap)
  • 2023 Cash Payout: $0 (0.00% of spending)
  • 2023 Cash to Cap Ratio: 0
  • Contract Value: $0 ($0 APY)
  • Fully Guaranteed Money: $0
  • Contract Ranking: 72/72 at C

Current Contract

(UFA, signed 2023)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryCap
Number
Cap %
Dead Money & Cap Savings
202332$0$00.0%
Total$0$0

Contract Notes

Hroniss Grasu signed a contract with the Tennessee Titans on February 7, 2019.  Contract is a one year deal worth $645,000.

Cash Flows

- fully earned money
- unearned or partially earned money
$0M
Cash Due
Running Cash
Career Earnings: $5,577,591
Career APY: $697,199
Potential Earnings: $3,914,773
Total Guarantees: $761,920
Largest Cash Payment: $1,196,920 (2015)
Largest Cap Number: $877,980 (2017)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
BearsDraftedTerminated20154$3,529,420$814,855$761,920$2,459,92069.7%$819,973
RavensSFATerminated20181$630,000$630,000$0$00.0%$0
DolphinsSFATerminated20181$630,000$630,000$0$00.0%$0
TitansSFATerminated20191$720,000$720,000$0$00.0%$0
TitansSFATerminated20191$720,000$720,000$0$00.0%$0
TitansSFATerminated20191$720,000$720,000$0$00.0%$0
RavensSFAExpired20191$720,000$720,000$0$169,41223.5%$169,412
49ersSFATerminated20201$910,000$910,000$0$00.0%$0
49ersPracticeElevated20201$245,529$245,529$0$00.0%$0
49ersPracticeElevated20201$204,000$204,000$0$00.0%$0
49ersPracticeRenegotiated20201$287,059$287,059$0$00.0%$0
49ersSFAExpired20201$910,000$910,000$0$802,94188.2%$802,941
RaidersPracticeExpired20211$252,000$252,000$0$195,00077.4%$195,000
RaidersSFATerminated20221$1,035,000$1,035,000$0$00.0%$0
RaidersPracticeRenegotiated20221$358,200$358,200$0$00.0%$0
RaidersSFAExpired20221$1,035,000$1,035,000$0$287,50027.8%$287,500
RaidersUFAActive20231$0$0$0$00.0%$0
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Bears3$2,459,920$819,973$2,269,4400.0%$190,4800.0%
Ravens1$502,942$502,942$169,4120.0%$333,5300.0%
Dolphins0$74,117$0$00.0%$74,1170.0%
Titans1$889,412$889,412$00.0%$847,0590.0%
49ers1$910,000$910,000$661,7650.0%$107,0590.0%
Raiders2$741,200$370,600$443,6110.0%$258,7000.0%

Season History

YearTeamBase SalaryProrated BonusCap
Number
Cap %Cash Paid
2015Bears$435,000$190,480$625,4800.4%$1,196,920
2016Bears$575,500$190,480$765,9800.5%$575,500
2017Bears$687,500$190,480$877,9800.5%$687,500
2018Titans$0$0$00.0%$0
2019Ravens$720,000$0$169,4120.1%$169,412
202049ers$910,000$0$661,7650.3%$802,941
2021Raiders$252,000$0$195,0000.1%$195,000
2022Raiders$1,035,000$0$248,6110.1%$287,500
2023Raiders$0$0$00.0%$0
Total$4,615,000$571,440$3,544,228$3,914,773
Dead Money History
TeamYearCap ChargeCash Paid
Bears2018$190,480$0
Ravens2018$333,530$333,530
Dolphins2018$74,117$74,117
Titans2019$169,412$169,412
Titans2019$720,000$720,000
Titans2020($42,353)$0
49ers2020$107,059$107,059
Raiders2022$258,700$258,700
Total$1,810,945$1,662,818

Statistics

YearGames PlayedGames InactiveSnaps
InjuredHealthyOffenseSpecial
201584451.3%0.0%
201765226.4%0.7%
20183056.7%2.5%
20191070.1%0.0%
202092019.7%3.8%
20224016.2%3.3%

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$601,000$0
Injury Adjusted$601,000$0
test
OTC Valuation $2M $4.1M $6.1M $8.2M $10.2M APY $2.3M $4.7M $7M $9.3M $11.7M $4,165,000 $4,750,000

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.